Literature DB >> 15755591

Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain).

L Salleras1, A Dominguez, M Bruguera, N Cardeñosa, J Batalla, G Carmona, E Navas, J L Taberner.   

Abstract

The aim of the study was to describe the impact of hepatitis B vaccination and disease incidence in adolescents and young people 12 years after the launching of a mass hepatitis B vaccination of pre-adolescents in schools. Vaccination coverage was assessed using administrative and serological data. Infection trends were evaluated by means of seroepidemiological surveys. High levels of vaccination coverage and vaccine-induced immunity were achieved. The resulting low proportions of susceptible adolescents and young people have undoubtedly contributed to the substantial reduction in the prevalence of hepatitis B infection in the 15-24 years age group (0.9 per 100 in 2001 versus 9.3 per 100 in 1986) and in the reported incidence of hepatitis B cases (80% reduction). Over the last 3 years, the declining trend seems to have been halted, although 35% of cases reported during this period corresponded to immigrants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755591     DOI: 10.1016/j.vaccine.2005.01.068

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Hepatitis B immunization strategies: timing is everything.

Authors:  Christopher O Mackie; Jane A Buxton; Sayali Tadwalkar; David M Patrick
Journal:  CMAJ       Date:  2009-01-20       Impact factor: 8.262

Review 2.  Hepatitis B virus epidemiology.

Authors:  Jennifer H MacLachlan; Benjamin C Cowie
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

3.  The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic.

Authors:  Narcisse P Komas; Souleyman Baï-Sepou; Alexandre Manirakiza; Josiane Léal; Aubin Béré; Alain Le Faou
Journal:  BMC Infect Dis       Date:  2010-07-29       Impact factor: 3.090

4.  Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia.

Authors:  H Chaouch; W Hachfi; I Fodha; O Kallala; S Saadi; A Bousaadia; F Lazrag; I Bougmiza; M Aouni; A Trabelsi; E Ben Jazia; A Letaief
Journal:  Epidemiol Infect       Date:  2016-08-18       Impact factor: 4.434

5.  Impact of universal vaccination against hepatitis B: the italian model.

Authors:  Rosa Cristina Coppola; Angelo Meloni; Marcello Campagna
Journal:  Hepat Mon       Date:  2012-07-30       Impact factor: 0.660

6.  The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).

Authors:  Manuel Oviedo; M Pilar Muñoz; Gloria Carmona; Eva Borrás; Joan Batalla; Nuria Soldevila; Angela Domínguez
Journal:  BMC Public Health       Date:  2012-08-06       Impact factor: 3.295

7.  An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.

Authors:  Giuseppe La Torre; Nicola Nicolotti; Chiara de Waure; Giacomina Chiaradia; Maria Lucia Specchia; Alice Mannocci; Walter Ricciardi
Journal:  Virol J       Date:  2008-07-24       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.